Investigations of 'quantum dots' for looking deeply into body tissues are rapidly evolving, but more work is required to...
Dr Sajikumar Sreedharan and undergraduate student Karen Pang, PhD student Mahima Sharma, post-doctoral fellow Dr. Krishn...
A team of researchers from the Centre for Nanoscale BioPhotonics (CNBP) in Australia has developed a new automated non-i...
ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manu...
Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...
Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfull...
Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were...
Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cell...
Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfi...
FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...
Ambrx Inc., a clinical-stage biopharmaceutical company focused on the development of innovative protein therapeutics and...
In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...
Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and ...
Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s diseas...
China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platfo...
A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...
Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...
Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-a...